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Abstract
Background:  Teratogen information services have been developed around the world to
disseminate information regarding the safety of maternal exposures during pregnancy. The
Motherisk Program in Toronto, Canada, fields thousands of these inquiries per year. Our primary
objective was to evaluate the perception and utilization of information received from us by
physicians. Our secondary objective was to examine their information seeking behavior, in
particular regarding teratogen information.
Methods: A one page survey was sent to physicians who had called Motherisk for information
concerning pregnancy exposures in the previous 30 days for three months. Among the questions
that were asked were demographics, which included gender, years in practice, specialty,
information resources, and how they utilized the information received from Motherisk.
Results: We received 118/200 completed questionnaires (59% response rate). The mean age of
the respondents was: 42 ± 9 years, mean years of practice was: 14 ± 8 years, males: 46(38%) and
females 72(62%) and 95(80%) were family physicians. 56(48%) researched their question prior to
calling Motherisk, 106(91%) and passed on the information received to their patient verbatim. The
top four resources for information were: 1) The CPS (PDR), 2) textbooks, 3) journals and 4)
colleagues. Only 8% used the Medline for gathering information.
Conclusions: Physicians feel that a teratogen information service is an important component in
the management of women exposed to drugs, chemicals, radiation and infections diseases etc.
during pregnancy. Despite the advent of the electronic age, a minority of the physicians in our
survey elected to use electronic means to seek information.
Background
Subsequent to the thalidomide tragedy, teratogen infor-
mation services were developed in response to the public
and health professionals need for evidence-based infor-
mation regarding the safety/risk of exposures to drugs,
chemicals, radiation and infectious diseases etc, during
pregnancy and lactation. The vast majority of these serv-
ices are telephone information lines, with a minority who
see the women in a clinic setting [1]. Because of the pau-
city of this type of information, several of the centers,
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often in collaboration with other services around the
world, also began to carry out outcome studies on the
safety/risk of various exposures, which have been and
continue to be published in peer reviewed journals. Over
the years as a group, they have also sought ways of
improving how this research is carried out [2]. This collab-
orative research has added substantially to the evidence
based information, culminating over the years in a rela-
tively large body of research in this field, which in turn can
be transferred to the women and their health care provid-
ers [3-12].
The Motherisk Program is a teratogen information service
that has been operating at The Hospital for Sick Children
in Toronto, Canada since 1985. Over the years there has
been a steady increase in the number of calls to our service
per year, with 31,000 in 2002. Adding to this number of
documented calls, there are approximately 12,000 callers
per year who listen to our recorded information and do
not patch through to a counselor, thus bringing up the
overall total number of calls the service receives to approx-
imately 43,000 calls per year. We also see between 450–
500 women per year in our clinic, where a letter is sent to
her attending physician following her visit, documenting
the evidence based information that was given to her
regarding her exposure and any other reproductive risks.
Approximately 3000 of the telephone calls a year are
directly from physicians. However, 90% of all the callers
have been referred to our line by their physicians, as our
service is very well known in Toronto and surrounding
areas, as well as a substantial number of calls from the rest
of Canada and the US. We have heard from many of our
callers that it is standard practice during a pregnant
women's first visit to her physician after confirmation of
pregnancy, to be given Motherisk's phone number in case
she has any questions regarding exposures during
pregnancy.
The physicians who call us, have told us that they had
heard about us mostly from word of mouth from their
colleagues or quite frequently from having read the
reviews which are published monthly in The Canadian
Family Physician journal as "The Motherisk Update".
These reviews evolve from actual questions asked by phy-
sicians using our fax service. Recently we published a his-
tory of our questions and answers and found that the
most common questions physicians ask are in order of
frequency: 1) antidepressants, 2) anti-epileptics, 3) anti-
histamines [13]. The physicians that call us on the tele-
phone do not receive written information as time
constraints do not allow, however if they request docu-
mentation, they are referred to our fax service. Most
appear to be satisfied with the information they receive
over the telephone, because it is rare that there is a request
for written information following a telephone call.
There is a relative lack of published research in the litera-
ture examining physicians information seeking behavior
in general and in particular reproductive toxicology. Stud-
ies carried out in the US, Canada, Norway, Australia and
Switzerland, found that little had changed in physician
information seeking behavior over the years despite the
increased access to medical information. In all studied
countries, use of electronic means to seek information was
low and most physicians relied heavily on word of mouth
from their colleagues, their own experience, drug product
monographs, textbooks and journals [14-18].
Over the years we have delivered information to thou-
sands of physicians via the telephone, but have never fol-
lowed up to assess how they perceive the information
received, or in turn how they use this information to
counsel their pregnant patients. Our objectives were to
assess utilization of information received, as well as infor-
mation seeking behavior, in particular teratogen
information.
Methods
The Motherisk Program has been participating in a course
for medical students for the past ten years, run by the Uni-
versity of Toronto Medical School entitled "Determinants
of Health in the Community" which aims to teach 2nd year
medical students about the inter-relationships between
health issues and social determinants of health, which
involves working with community agencies. The 2002–
2003 student, developed a one page questionnaire, (see
additional file 1) which was faxed to the physicians. The
form consisted of 12 questions which could be filled out
in less than 5 minutes following pilot testing. The first 6
questions dealt with demographics, such as age, gender,
speciality, length of practice and numbers of pregnant
women seen each year. The next 3 questions asked about
information seeking behaviour. We listed eight resources
to choose from: medline (PUBMED), colleagues, drug
companies, textbooks, peer reviewed journals, media,
Compendium of Pharmaceuticals and Specialties (CPS),
which is the Canadian equivalent to the Physicians Desk
Reference (PDI) in the USA and patients. They were then
asked to rank in order their most frequently used
resources. The latter part of the questionnaire asked sev-
eral questions pertaining to the information that was
received from Motherisk and how it was perceived by
them in terms of clinical importance. At the end of the
questionnaire, two lines were left empty and in this space
participants were invited to make any additional com-
ments. We chose to use a convenience sample of physi-
cians who had called Motherisk requesting information in
December 2002, January and February 2003. They wereBMC Medical Education 2004, 4 http://www.biomedcentral.com/1472-6920/4/6
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faxed the questionnaire within 1–2 weeks after their tele-
phone call to Motherisk. To improve the response rate, the
physician was sent a reminder fax 1 week after the first
one.
Descriptive statistics in numbers and percentages were
used to describe results.
Results
200 questionnaires were sent out to physicians who had
called the program over a three month period and 118
were returned, with a response rate of 59%. They origi-
nated from all over Canada, with 46 from Toronto and
surrounding areas, 38 from other parts of Ontario and the
remaining 34 distributed throughout the rest of the coun-
try from all provinces. The demographics of the physi-
cians are described in (Table 1). Most of the respondents
(91%) passed on the information to their patients verba-
tim, despite the fact that almost half had researched the
question prior to calling Motherisk. 12 of the respondents
reported that they suggested a lower dose of the drug they
prescribed to their pregnant patients and most of them
reported the information they received was not different
than they had expected. The top four sources for informa-
tion were 1) The CPS, (PDR), 2) textbooks, 3) journals, 4)
colleagues. (Table 2) Only 8% described the medline as
being their number one source of information.
Most of the physicians (89%) made comments at the bot-
tom of the questionnaire, saying the services of Motherisk
was very valuable to them and how they routinely pass on
the telephone number to their patients. Several men-
tioned that the information from Motherisk is docu-
mented in the patient's chart as "information given to
patient as per Motherisk".
Discussion
To our knowledge, this is the first study of its kind to eval-
uate physicians perceptions and utilization of informa-
tion received from a teratogen information service.
There were several interesting findings. Half of the
respondents described researching their question first and
almost all described the information not different than
they expected. These findings lead us to believe that this
group of physicians are perhaps not necessarily calling
Motherisk for new information, but rather for reassur-
ance. This confirms the findings of a study published
where the authors found that physicians consult on aver-
age at least 3 sources before adopting a practice [19].
The finding of the 10% who advised their patient to lower
the dosage of the drug, reflect a trend to lower drug dos-
age, often to ineffective levels during pregnancy, which we
have found in other studies we carried out regarding anti-
depressant use during pregnancy. We never advise physi-
cians to lower the dosage of a particular drug, we have
found that they counsel their patients due to fears of tera-
togenicity and feel if the dose is reduced this may lower
the teratogenic risk [20,21].
The findings regarding physicians information seeking
behavior, also confirmed the results in other studies
examining such behavior. Previous researchers found that
while more than 90% of physicians owned a computer,
less than 10% were using them to access Medline [14-18].
We were aware that physicians were not using this service,
because often women who call us will tell us that they
called their physician prior to contacting Motherisk and
was told that there was no information on the safety of a
particular drug in pregnancy. Later the counselor would
find a published study on the Medline and we would have
to assume that the physician did not attempt to look up
the information.
It was also interesting to note that far more female physi-
cians called us than males; 62% versus 38%. It is difficult
to explain why this was so, one of the reasons (we have
been told this by our callers), could be that more women
today choose a physician that is female, so consequently
more females would be the attending physician when a
woman becomes pregnant.
There are several limitations to this study, mainly the sam-
ple size is small and our response rate was not extremely
high (59%). It could be that the physicians who did not
return the questionnaire or who do not call Motherisk for
Table 1: Demographics of respondents N = 118
Age: mean ± SD 42 ± 9 years
Gender female = 62% male = 38%
Specialty family physicians = 80%
OBS/Gynecology = 9%
other 11%
Years of practice: mean ± SD 14 ± 9 years
Table 2: Perception and utilization of information N= 118
Question %
Research prior to calling Motherisk 48
Was information sufficient 100
Was information passed on verbatim to patient 91
Was information different than expected 6
Did you lower dose of drug 10BMC Medical Education 2004, 4 http://www.biomedcentral.com/1472-6920/4/6
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information may be very different from the respondents.
They may be the ones who are consulting electronic
means for information and feel comfortable with the
information they have in counseling pregnant women on
exposures in pregnancy. Another limitation, is that this
survey was completed by physicians who were inquiring
about teratogen information and the results may not be
applicable to physician information seeking behaviors in
general.
In summary, the results of our survey furnished us with
information that allows us to better understand how phy-
sicians perceive this type of service and how they transfer
the information to their pregnant patients. It was reassur-
ing to know that physicians respect and trust the data that
is given to them by a teratogen information service, which
was evidenced by most of them passing on the informa-
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